To further assess whether ANGPTL4 and its downstream signaling pathways influence clinical outcomes in human breast cancer, we analyzed several annotated breast tumor datasets to compare ANGPTL4 expression across different breast cancer subtypes and among patients with varying body mass index (BMI). The gene discussed is ANGPTL4; the disease is breast neoplasm.